Lung cancer, Non small cell lung cancer (NSCLC)
Results
Phase 3
This trial was looking at a drug called nivolumab to treat non small cell lung cancer (NSCLC) that has grown into surrounding tissues or spread to another part of the body (advanced cancer). The people taking part had a type of NSCLC called squamous cell cancer.
Recruitment start: 6 February 2013
Recruitment end: 8 November 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Christian Ottensmeier
Bristol-Myers Squibb
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network; Cancer
Last reviewed: 13 Jan 2016
CRUK internal database number: 10188
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
